Original Research
Published on 13 Jun 2024
A real-world disproportionality analysis of Tivozanib data mining of the public version of FDA adverse event reporting system
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1408135
- 3,606 views
- 7 citations


